The Fission Converter-Based Epithermal Neutron Irradiation Facility at the Massachusetts Institute of Technology Reactor

Abstract A new type of epithermal neutron irradiation facility for use in neutron capture therapy has been designed, constructed, and put into operation at the Massachusetts Institute of Technology Research Reactor (MITR). A fission converter, using plate-type fuel and driven by the MITR, is used as the source of neutrons. After partial moderation and filtration of the fission neutrons, a high-intensity forward directed beam is available with epithermal neutron flux [approximately equal to]1010 n/cm2·s, 1 eV ≤ E ≤ 10 keV, at the entrance to the medical irradiation room, and epithermal neutron flux = 3 to 5 × 109 n/cm2·s at the end of the patient collimator. This is currently the highest-intensity epithermal neutron beam. Furthermore, the system is designed and licensed to operate at three times higher power and flux should this be desired. Beam contamination from unwanted fast neutrons and gamma rays in the aluminum, polytetrafluoroethylene, cadmium and lead-filtered beam is negligible with a specific fast neutron and gamma dose, Dγ,fn/ϕepi [less than or approximately equal] 2 × 10–13 Gy cm2/nepi. With a currently approved neutron capture compound, boronophenylalanine, the therapeutically advantageous depth of penetration is >9 cm for a unilateral beam placement. Single fraction irradiations to tolerance can be completed in 5 to 10 min. An irradiation control system based on beam monitors and redundant, high-reliability programmable logic controllers is used to control the three beam shutters and to ensure that the prescribed neutron fluence is accurately delivered to the patient. A patient collimator with variable beam sizes facilitates patient irradiations in any desired orientation. A shielded medical room with a large window provides direct viewing of the patient, as well as remote viewing by television. Rapid access through a shielded and automatically operated door is provided. The D2O cooling system for the fuel has been conservatively designed with excess capacity and is fully instrumented to ensure detection and control of off-normal conditions. A wide range of possible abnormal events or accident scenarios has been analyzed to show that even in the worst cases, there should be no fission product release through fuel damage. This facility has been licensed to operate by the U.S. Nuclear Regulatory Commission, and initial operation commenced in June 2000.

[1]  A D Chanana,et al.  Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. , 1998, Radiation research.

[2]  J. F. Briesmeister.  MCNP-A General Monte Carlo N-Particle Transport Code , 1993 .

[3]  O. Harling,et al.  Head phantoms for neutron capture therapy. , 1995, Medical physics.

[4]  D. Nigg,et al.  Experimental investigation of filtered epithermal-photoneutron Beams for BNCT , 1996 .

[5]  R. Moss,et al.  Design, Construction and Installation of an Epithermal Neutron Beam for BNCT at the High Flux Reactor Petten , 1992 .

[6]  H. B. Liu,et al.  The requirements and development of neutron beams for neutron capture therapy of brain cancer , 1997, Journal of Neuro-Oncology.

[7]  J. Gajewski,et al.  An Optimized Epithermal Neutron Beam for Neutron Capture Therapy (NCT) at the Brookhaven Medical Research Reactor (BMRR) , 1992 .

[8]  O. Harling,et al.  Monte Carlo methods of neutron beam design for neutron capture therapy at the MIT Research Reactor (MITR-II). , 1990, Basic life sciences.

[9]  J. Coderre,et al.  The radiation biology of boron neutron capture therapy. , 1999, Radiation research.

[10]  D. Wazer,et al.  A PHASE-I DOSE-ESCALATION TRIAL OF BORON NEUTRON CAPTURE THERAPY FOR SUBJECTS WITH METASTATIC SUBCUTANEOUS MELANOMA OF THE EXTREMITIES , 1996 .

[11]  R. Bergland,et al.  Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy. , 1998, Neurosurgery.

[12]  O. Harling.  Boron neutron capture therapy research at the MIT research reactor , 1994 .

[13]  W. Sweet.  Early history of development of boron neutron capture therapy of tumors , 1997, Journal of Neuro-Oncology.

[14]  Jacquelyn C. Yanch,et al.  Monte Carlo simulation of the Massachusetts Institute of Technology Research Reactor , 1994 .

[15]  D. Slatkin,et al.  Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies , 1999, Neurosurgery.

[16]  O. Harling,et al.  Mixed field dosimetry of epithermal neutron beams for boron neutron capture therapy at the MITR-II research reactor. , 1994, Medical physics.

[17]  R. Rogus.  Design and dosimetry of epithermal neutron beams for clinical trials of boron neutron capture therapy at the MITR-II reactor , 1994 .

[18]  J. Bernard,et al.  Boron Neutron Capture Therapy and Radiation Synovectomy Research at the Massachusetts Institute of Technology Research Reactor , 1992 .

[19]  Y. Oda.  [Boron neutron capture therapy]. , 1989, Nihon geka hokan. Archiv fur japanische Chirurgie.

[20]  O. Harling,et al.  Sensitivity studies of beam directionality, beam size, and neutron spectrum for a fission converter-based epithermal neutron beam for boron neutron capture therapy. , 1999, Medical physics.

[21]  B. V. Harrington.  A calculational study of tangential and radial beams in HIFAR for neutron capture therapy. , 1990, Basic life sciences.

[22]  Kent J. Riley,et al.  Construction and characterization of a fission converter based epithermal neutron beam for BNCT , 2001 .

[23]  A. Soloway,et al.  Boron neutron capture therapy for cancer. Realities and prospects , 1992 .

[24]  Otto K. Harling,et al.  Neutronic design of a fission converter-based epithermal neutron beam for neutron capture therapy , 1999 .

[25]  I. Auterinen,et al.  Epithermal BNCT Neutron Beam Design for a Triga II Reactor , 1993 .

[26]  R. Brugger,et al.  Conceptual Designs of Epithermal Neutron Beams for Boron Neutron Capture Therapy from Low-Power Reactors , 1994 .

[27]  G. Brownell,et al.  Boron neutron capture therapy for the treatment of cerebral gliomas. I. Theoretical evaluation of the efficacy of various neutron beams. , 1975, Medical physics.

[28]  O. Harling,et al.  A Monte Carlo Study of Ideal Beams for Epithermal Neutron Beam Development for Boron Neutron Capture Therapy , 1992 .

[29]  Balendra Sutharshan,et al.  Engineering design of a fission converter-based epithermal beam for neutron capture therapy , 1998 .

[30]  R. Barth,et al.  Boron neutron capture therapy of cancer. , 1990, Cancer research.

[31]  T. Watanabé.  [Neutron capture therapy]. , 1971, Gan no rinsho. Japan journal of cancer clinics.

[32]  I. Kaplan,et al.  The Harvard-MIT BNCT Program , 2001 .

[33]  O. Harling,et al.  On-line beam monitoring for neutron capture therapy at the MIT Research Reactor , 1995 .

[34]  H. Fukuda,et al.  [Neutron capture therapy for cancer]. , 1994, Gan to kagaku ryoho. Cancer & chemotherapy.